Elevated levels of the anti-angiogenic factors antagonize the effects of the pro-angiogenic factors, vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) leading to widespread endothelial dysfunction [4–6] and the clinical features of preeclampsia [1, 2]. This evidence concerns the gene VEGFA and preeclampsia.